Galaxy Surfactants Ltd
Galaxy Surfactants Ltd was Incorporated in 1986. It’s a leading manufacturer of Performance Surfactants and Specialty Care products with over 205 product grades. These products are used in consumer-centric Home and Personal care products like hair care, oral care, skin care, cosmetics, soap, shampoo, lotion, detergent, cleaning products, etc. Preferred suppliers to leading MNC’s, Regional and Local FMCG brands.[1]
The company is India’s Largest Manufacturer of Oleo chemical-based Surfactants and Specialty Care Products for Home Care and Personal Care Industries [2]
- Market Cap ₹ 9,580 Cr.
- Current Price ₹ 2,702
- High / Low ₹ 3,370 / 2,241
- Stock P/E 49.4
- Book Value ₹ 403
- Dividend Yield 0.81 %
- ROCE 19.0 %
- ROE 15.3 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 41.0%
Cons
- The company has delivered a poor sales growth of 6.57% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE 400 MidSmallCap Index BSE Commodities BSE 500 BSE 250 SmallCap Index BSE Allcap
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,418 | 1,427 | 1,472 | 1,343 | 1,500 | 1,683 | 1,996 | 1,792 | 1,829 | 2,628 | 3,176 | 2,744 | 2,839 | |
1,287 | 1,234 | 1,295 | 1,138 | 1,311 | 1,484 | 1,728 | 1,511 | 1,536 | 2,394 | 2,818 | 2,426 | 2,537 | |
Operating Profit | 131 | 194 | 176 | 205 | 189 | 200 | 268 | 281 | 293 | 234 | 359 | 318 | 301 |
OPM % | 9% | 14% | 12% | 15% | 13% | 12% | 13% | 16% | 16% | 9% | 11% | 12% | 11% |
4 | 8 | 8 | 9 | 35 | 13 | 36 | 5 | 4 | -1 | -6 | 24 | 27 | |
Interest | 51 | 38 | 31 | 26 | 21 | 21 | 20 | 17 | 8 | 8 | 12 | 12 | 13 |
Depreciation | 33 | 33 | 24 | 23 | 25 | 28 | 29 | 40 | 50 | 44 | 53 | 63 | 65 |
Profit before tax | 51 | 130 | 130 | 165 | 179 | 164 | 254 | 230 | 239 | 181 | 288 | 267 | 251 |
Tax % | 33% | 35% | 35% | 35% | 32% | 32% | 34% | 21% | 26% | 26% | 26% | 25% | |
34 | 84 | 85 | 107 | 121 | 112 | 168 | 182 | 178 | 134 | 214 | 200 | 194 | |
EPS in Rs | 9.67 | 23.74 | 24.02 | 30.24 | 34.05 | 31.71 | 47.51 | 51.38 | 50.17 | 37.76 | 60.36 | 56.51 | 54.71 |
Dividend Payout % | 26% | 4% | 17% | 30% | 18% | 22% | 17% | 27% | 36% | 48% | 36% | 39% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 7% |
3 Years: | 14% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | 9% |
5 Years: | 4% |
3 Years: | 4% |
TTM: | -15% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | -3% |
1 Year: | -4% |
Return on Equity | |
---|---|
10 Years: | 19% |
5 Years: | 17% |
3 Years: | 15% |
Last Year: | 15% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 |
Reserves | 231 | 311 | 378 | 446 | 532 | 630 | 747 | 854 | 981 | 1,102 | 1,188 | 1,370 | 1,393 |
347 | 255 | 264 | 270 | 247 | 218 | 158 | 199 | 171 | 257 | 192 | 133 | 95 | |
208 | 253 | 201 | 211 | 286 | 354 | 366 | 300 | 369 | 485 | 447 | 452 | 563 | |
Total Liabilities | 822 | 854 | 878 | 963 | 1,100 | 1,238 | 1,307 | 1,389 | 1,558 | 1,880 | 1,863 | 1,990 | 2,087 |
289 | 264 | 255 | 238 | 275 | 281 | 359 | 477 | 463 | 488 | 630 | 632 | 660 | |
CWIP | 3 | 4 | 5 | 46 | 10 | 19 | 40 | 61 | 116 | 178 | 84 | 155 | 212 |
Investments | 120 | 120 | 120 | 218 | 216 | 223 | 256 | 218 | 217 | 208 | 200 | 220 | 186 |
410 | 467 | 498 | 462 | 599 | 715 | 651 | 632 | 761 | 1,006 | 949 | 983 | 1,028 | |
Total Assets | 822 | 854 | 878 | 963 | 1,100 | 1,238 | 1,307 | 1,389 | 1,558 | 1,880 | 1,863 | 1,990 | 2,087 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
76 | 135 | 52 | 198 | 91 | 103 | 238 | 212 | 184 | 46 | 331 | 238 | |
-51 | -6 | -14 | -141 | -40 | -41 | -126 | -39 | -105 | -109 | -104 | -142 | |
-19 | -131 | -36 | -59 | -54 | -64 | -110 | -161 | -84 | 59 | -214 | -96 | |
Net Cash Flow | 6 | -2 | 2 | -1 | -3 | -3 | 2 | 13 | -5 | -4 | 14 | 0 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 48 | 59 | 62 | 61 | 70 | 72 | 56 | 56 | 68 | 66 | 53 | 61 |
Inventory Days | 44 | 51 | 50 | 52 | 69 | 68 | 56 | 64 | 86 | 80 | 55 | 64 |
Days Payable | 56 | 72 | 52 | 64 | 80 | 92 | 73 | 72 | 97 | 81 | 61 | 71 |
Cash Conversion Cycle | 35 | 38 | 60 | 50 | 59 | 48 | 39 | 48 | 56 | 64 | 47 | 53 |
Working Capital Days | 29 | 37 | 56 | 52 | 60 | 63 | 42 | 53 | 73 | 70 | 53 | 62 |
ROCE % | 18% | 28% | 25% | 27% | 25% | 22% | 30% | 24% | 22% | 15% | 21% | 19% |
Documents
Announcements
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
7h - Intimation of loss of share certificates by shareholder.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
2d - Transcript of Concall for Q2 and H1 of FY 2024-25
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
18 Nov - Intimation of loss of share certificate by shareholder.
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 15 Nov
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
13 Nov - Link of audio recording of investor con call
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT REC
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Jun 2021TranscriptNotesPPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020TranscriptPPT
-
Jun 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jun 2019Transcript PPT
-
May 2019TranscriptNotesPPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Nov 2018TranscriptNotesPPT
-
Aug 2018Transcript PPT
-
May 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
Mar 2018Transcript PPT
Product Portfolio
The co. offers 210+ Products under its Performance Surfactants and Speciality Care Products which includes varieties of products under hair care, oral care, home care, skin care, cosmetics and toiletries. [1] [2]